Skip to content
healthcare.dev
Get a free key

EDURANT PED

NDC 59676-280, rilpivirine hydrochloride, tablet, for suspension, from Janssen Products, LP.

Product NDC
59676-280
Status
Listed
Labeler
Janssen Products, LP
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219016
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59676-280 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RILPIVIRINE HYDROCHLORIDE2.5 mg/1

Pharmacologic classes

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
59676-280-90596760280909 BLISTER PACK in 1 CARTON (59676-280-90) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (59676-280-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/03880372-2c68-45c6-a53a-f420c49541d6

Use it

Look up 59676-280 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59676-280 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59676-280. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.